Barbara Engelhardt

Prof. Barbara Engelhardt


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2015 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
GCGenetics of Personality Consortium
Genetics of Personality Consortium
MMMarleen H. M. de Moor
Marleen H. M. de Moor
SBStephanie M. Van den Berg
Stephanie M. Van den Berg
KVKarin J. H. Verweij
Karin J. H. Verweij
RKRobert F. Krueger
Robert F. Krueger
DBDorret I. Boomsma
Dorret I. Boomsma
Dimensions of personality have been linked with the liability to have psychiatric illness.1 Perhaps the strongest link between personality and psychiatric illness is the association of neuroticism with major depressive disorder (MDD).2-5 Neuroticism is also associated with other psychiatric disorders that entail emotional dysregulation, including personality, substance use, and anxiety disorders.2,6-8 Furthermore, neuroticism is associated with neurological diseases such as migraine and Alzheimer disease.9,10 Hence, neuroticism is a psychological risk factor of profound public health significance.11

23 February 2017 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
JCJonathan D Cohen
Jonathan D Cohen
NDNathaniel Daw
Nathaniel Daw
BEBarbara Engelhardt
Barbara Engelhardt
UHUri Hasson
Uri Hasson
KLKai Li
Kai Li
TWTheodore L Willke
Theodore L Willke

28 August 2013 in Nature
Verified
Journal Article
Open access
PDF file
LMLara M. Mangravite
Lara M. Mangravite
BEBarbara Engelhardt
Barbara Engelhardt
MMMarisa W. Medina
Marisa W. Medina
JSJoshua D. Smith
Joshua D. Smith
CBChristopher D. Brown
Christopher D. Brown
RKRon Krauss
Ron Krauss
Exploration of the interacting effect of statin exposure and genetic variation on gene expression identifies a cis-eQTL that is differentially associated with expression of the GATM gene, which encodes a rate-limiting enzyme involved in creatine synthesis, and that is associated with incidence of statin-induced myopathy, the major adverse effect of statin treatment. Statins are widely prescribed for lowering plasma low-density lipoprotein (LDL) concentrations, thereby reducing cardiovascular disease risk, but response to treatment varies and there is concern about potential adverse effects. Lara Mangravite et al. screened for the effects of in vitro statin exposure on genetic associations with gene expression levels in lymphoblastoid cell lines derived from participants of a clinical trial of simvastatin treatment. They identified six expression quantitative trait loci that interact with simvastatin exposure, including one that affects the GATM gene encoding glycine amidinotransferase, a rate-limiting enzyme in creatine synthesis. They also provide evidence to suggest that GATM acts as a functional link between statin-mediated cholesterol reduction and susceptibility to myopathy, a common side effect of statin therapy. Statins are prescribed widely to lower plasma low-density lipoprotein (LDL) concentrations and cardiovascular disease risk1 and have been shown to have beneficial effects in a broad range of patients2,3. However, statins are associated with an increased risk, albeit small, of clinical myopathy4 and type 2 diabetes5. Despite evidence for substantial genetic influence on LDL concentrations6, pharmacogenomic trials have failed to identify genetic variations with large effects on either statin efficacy7,8,9 or toxicity10, and have produced little information regarding mechanisms that modulate statin response. Here we identify a downstream target of statin treatment by screening for the effects of in vitro statin exposure on genetic associations with gene expression levels in lymphoblastoid cell lines derived from 480 participants of a clinical trial of simvastatin treatment7. This analysis identified six expression quantitative trait loci (eQTLs) that interacted with simvastatin exposure, including rs9806699, a cis-eQTL for the gene glycine amidinotransferase (GATM) that encodes the rate-limiting enzyme in creatine synthesis. We found this locus to be associated with incidence of statin-induced myotoxicity in two separate populations (meta-analysis odds ratio = 0.60). Furthermore, we found that GATM knockdown in hepatocyte-derived cell lines attenuated transcriptional response to sterol depletion, demonstrating that GATM may act as a functional link between statin-mediated lowering of cholesterol and susceptibility to statin-induced myopathy.

1 August 2013 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
CBChristopher D. Brown
Christopher D. Brown
LMLara M. Mangravite
Lara M. Mangravite
BEBarbara Engelhardt
Barbara Engelhardt
Genetic variants in cis-regulatory elements or trans-acting regulators frequently influence the quantity and spatiotemporal distribution of gene transcription. Recent interest in expression quantitative trait locus (eQTL) mapping has paralleled the adoption of genome-wide association studies (GWAS) for the analysis of complex traits and disease in humans. Under the hypothesis that many GWAS associations tag non-coding SNPs with small effects, and that these SNPs exert phenotypic control by modifying gene expression, it has become common to interpret GWAS associations using eQTL data. To fully exploit the mechanistic interpretability of eQTL-GWAS comparisons, an improved understanding of the genetic architecture and causal mechanisms of cell type specificity of eQTLs is required. We address this need by performing an eQTL analysis in three parts: first we identified eQTLs from eleven studies on seven cell types; then we integrated eQTL data with cis-regulatory element (CRE) data from the ENCODE project; finally we built a set of classifiers to predict the cell type specificity of eQTLs. The cell type specificity of eQTLs is associated with eQTL SNP overlap with hundreds of cell type specific CRE classes, including enhancer, promoter, and repressive chromatin marks, regions of open chromatin, and many classes of DNA binding proteins. These associations provide insight into the molecular mechanisms generating the cell type specificity of eQTLs and the mode of regulation of corresponding eQTLs. Using a random forest classifier with cell specific CRE-SNP overlap as features, we demonstrate the feasibility of predicting the cell type specificity of eQTLs. We then demonstrate that CREs from a trait-associated cell type can be used to annotate GWAS associations in the absence of eQTL data for that cell type. We anticipate that such integrative, predictive modeling of cell specificity will improve our ability to understand the mechanistic basis of human complex phenotypic variation. When interpreting genome-wide association studies showing that specific genetic variants are associated with disease risk, scientists look for a link between the genetic variant and a biological mechanism behind that disease. One functional mechanism is that the genetic variant may influence gene transcription via a co-localized genomic regulatory element, such as a transcription factor binding site within an open chromatin region. Often this type of regulation occurs in some cell types but not others. In this study, we look across eleven gene expression studies with seven cell types and consider how genetic transcription regulators, or eQTLs, replicate within and between cell types. We identify pervasive allelic heterogeneity, or transcriptional control of a single gene by multiple, independent eQTLs. We integrate extensive data on cell type specific regulatory elements from ENCODE to identify general methods of transcription regulation through enrichment of eQTLs within regulatory elements. We also build a classifier to predict eQTL replication across cell types. The results in this paper present a path to an integrative, predictive approach to improve our ability to understand the mechanistic basis of human phenotypic variation.

11 September 2015 in Behavior Genetics
Verified
Journal Article
Open access
PDF file
GSGeneration Scotland
Generation Scotland
SBStephanie M. Van den Berg
Stephanie M. Van den Berg
MMMarleen H. M. de Moor
Marleen H. M. de Moor
KVKarin J. H. Verweij
Karin J. H. Verweij
RKRobert F. Krueger
Robert F. Krueger
DBDorret I. Boomsma
Dorret I. Boomsma
Extraversion is a relatively stable and heritable personality trait associated with numerous psychosocial, lifestyle and health outcomes. Despite its substantial heritability, no genetic variants have been detected in previous genome-wide association (GWA) studies, which may be due to relatively small sample sizes of those studies. Here, we report on a large meta-analysis of GWA studies for extraversion in 63,030 subjects in 29 cohorts. Extraversion item data from multiple personality inventories were harmonized across inventories and cohorts. No genome-wide significant associations were found at the single nucleotide polymorphism (SNP) level but there was one significant hit at the gene level for a long non-coding RNA site (LOC101928162). Genome-wide complex trait analysis in two large cohorts showed that the additive variance explained by common SNPs was not significantly different from zero, but polygenic risk scores, weighted using linkage information, significantly predicted extraversion scores in an independent cohort. These results show that extraversion is a highly polygenic personality trait, with an architecture possibly different from other complex human traits, including other personality traits. Future studies are required to further determine which genetic variants, by what modes of gene action, constitute the heritable nature of extraversion.

24 January 2015 in Genome Biology
Verified
Journal Article
Open access
PDF file
WZWeiwei Zhang
Weiwei Zhang
TSTim D Spector
Tim D Spector
PDPanos Deloukas
Panos Deloukas
JBJordana T Bell
Jordana T Bell
BEBarbara Engelhardt
Barbara Engelhardt
Background: Recent assays for individual-specific genome-wide DNA methylation profiles have enabled epigenome-wide association studies to identify specific CpG sites associated with a phenotype. Computational prediction of CpG site-specific methylation levels is critical to enable genome-wide analyses, but current approaches tackle average methylation within a locus and are often limited to specific genomic regions. Results: We characterize genome-wide DNA methylation patterns, and show that correlation among CpG sites decays rapidly, making predictions solely based on neighboring sites challenging. We built a random forest classifier to predict methylation levels at CpG site resolution using features including neighboring CpG site methylation levels and genomic distance, co-localization with coding regions, CpG islands (CGIs), and regulatory elements from the ENCODE project. Our approach achieves 92% prediction accuracy of genome-wide methylation levels at single-CpG-site precision. The accuracy increases to 98% when restricted to CpG sites within CGIs and is robust across platform and cell-type heterogeneity. Our classifier outperforms other types of classifiers and identifies features that contribute to prediction accuracy: neighboring CpG site methylation, CGIs, co-localized DNase I hypersensitive sites, transcription factor binding sites, and histone modifications were found to be most predictive of methylation levels. Conclusions: Our observations of DNA methylation patterns led us to develop a classifier to predict DNA methylation levels at CpG site resolution with high accuracy. Furthermore, our method identified genomic features that interact with DNA methylation, suggesting mechanisms involved in DNA methylation modification and regulation, and linking diverse epigenetic processes.